| October 30, 2003 |
October 30, 2003
Cerus Corporation Announces Third Quarter Results
|
| October 23, 2003 |
October 23, 2003
Cerus Corporation and the National Marrow Donor Program Initiate a Phase IB Clinical Trial for Stem Cell Transplants
|
| October 15, 2003 |
October 15, 2003
Cerus Realigns Development Efforts and Reduces Expenses
|
| October 15, 2003 |
October 15, 2003
Cerus Announces Loan Dispute With Baxter Capital
|
| September 18, 2003 |
September 18, 2003
Cerus to Present at the UBS Warburg Global Life Sciences Conference
|
| September 4, 2003 |
September 4, 2003
Baxter and Cerus Halt Red Blood Cell Clinical Trials for Investigational Pathogen Inactivation System
|
| July 24, 2003 |
July 24, 2003
Cerus Corporation Announces Second Quarter Results
|
| July 23, 2003 |
July 23, 2003
Cerus Reports Inactivation of SARS Virus with INTERCEPT Blood System; In Vitro Results Show that the Pathogen Inactivation Technology Kills Human SARS Virus in Blood
|
| July 13, 2003 |
July 13, 2003
Cerus Corporation Invites You to Join a Webcast of Its Second Quarter Financial Results Conference Call
|
| June 6, 2003 |
June 6, 2003
Cerus Announces Pricing of Public Offering
|
| June 4, 2003 |
June 4, 2003
Baxter and Cerus Reach Agreement with FDA on Steps to Gain Regulatory Approval for Innovative Pathogen Inactivation System
|
| June 3, 2003 |
June 3, 2003
Cerus Corporation Public Offering of Common Stock
|
| May 28, 2003 |
May 28, 2003
Timothy B. Anderson Joins Cerus Board of Directors.
|
| May 19, 2003 |
May 19, 2003
Cerus Corporation Receives Additional $6.2 Million Award in Ongoing Collaboration with the U.S. Armed Forces
|
| April 28, 2003 |
April 28, 2003
Cerus Corporation Announces First Quarter Results
|
| April 11, 2003 |
April 11, 2003
Cerus Corporation Invites You to Join a Webcast of Its First Quarter Financial Results Conference Call
|
| March 31, 2003 |
March 31, 2003
Cerus Receives FDA Concurrence to Expand Inclusion Criteria for Phase III INTERCEPT Red Blood Cell Trial in Chronic Indications
|
| February 4, 2003 |
February 4, 2003
Cerus Corporation Starts Vaccine Trial for Epstein-Barr Virus
|
| January 30, 2003 |
January 30, 2003
Cerus Corporation Announces Fourth Quarter and Year End Results
|
| January 23, 2003 |
January 23, 2003
Cerus Corporation Names Laurence M. Corash, M.D. to Board of Directors
|
| January 20, 2003 |
January 20, 2003
Baxter and Cerus Announce the First Customers for the Intercept Blood System
|
| January 17, 2003 |
January 17, 2003
Cerus Corporation Invites You to Join a Webcast of its Fourth Quarter and Year End Conference Call
|